Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?
Ekim Ekinci(Houston Methodist), Meghana V. Trivedi(University of Houston), Aisha Vadhariya(University of Houston), Polly Niravath(Houston Methodist), Thushara Korattyil(University of Houston), Hanna Zaghloul(Houston Methodist), Salima Nathoo(University of Houston), Susan Abughosh(University of Houston)
Cited by 72
Related Papers
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
|Cancer Research|2018|221
Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications
|Breast Care|2013|200
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
|Proceedings of the National Academy of Sciences|2016|185
The changing role of ER in endocrine resistance
|The Breast|2015|133